3.1 Endogenous Enzyme Blocking

Endogenous reporter-like enzymes are already in the tissue. Detection systems then add horseradish peroxidase (HRP) or alkaline phosphatase (AP) as the intended catalyst. If you apply chromogen without first silencing the tissue enzymes, red cells, granulocytes, and some epithelia deposit the same color as a true antibody-enzyme reaction. That false deposit is not overstaining of antigen. It is enzyme activity that never needed an antibody.

This section stays inside detection-system chemistry: how hydrogen peroxide and levamisole remove those tissue enzymes, when the block sits relative to epitope retrieval, why frozen and formalin-fixed paraffin-embedded (FFPE) slides do not behave the same, and how an overly aggressive block can weaken the very HRP or AP you just applied. Biotin-free polymer detection does not replace these enzyme blocks. Polymer removes avidin-biotin chemistry; it does not remove heme or tissue AP.

Why the block exists

HRP detection with DAB or AEC reads any peroxidase-like activity. Human tissues contain catalase, cytochromes, and hemoglobin. Hemoglobin in erythrocytes has pseudoperoxidase activity: it reduces peroxide and oxidizes DAB to a brown polymer that looks like cytoplasmic immunoreactivity if morphology is ignored. Neutrophils, eosinophils, and some macrophages carry true myeloperoxidase. A bloody marrow clot, hemorrhagic tumor, spleen, or granulation-tissue biopsy can therefore stain brown even on the negative reagent control.

AP detection with Fast Red, Permanent Red, or BCIP/NBT reads tissue alkaline phosphatase. Small-intestinal brush border, proximal renal tubules, placenta, osteoblasts, regenerating bile ductules, and neutrophils are the usual sources. FFPE processing and heat-induced epitope retrieval (HIER) destroy much of this activity. Frozen sections, smears, and some lightly fixed cytology preparations keep it.

The clinical job is selective inactivation: stop tissue enzyme, leave the detection enzyme you will add later, and leave the epitope intact.

Hydrogen peroxide for HRP: aqueous versus methanol

Hydrogen peroxide inactivates peroxidase by oxidizing the heme catalytic center. Typical working strength is about 3% H2O2 in water or buffer for 5–10 minutes on FFPE, or a more dilute 0.3% H2O2 in methanol for 10–30 minutes when methanol is the vehicle. Neither number is a universal standard; the laboratory's validated protocol owns time and concentration. What you must be able to explain is the vehicle.

Aqueous hydrogen peroxide (3% in distilled water, PBS, or TBS) is the default on most FFPE polymer-HRP runs. It does not add a second organic fixative. Membrane antigens that are unhappy in methanol—some leukocyte CD markers, some glycoprotein epitopes—are safer in aqueous peroxide. The tradeoff is penetration: intact red-cell membranes and densely packed heme can be incompletely quenched, so residual erythrocyte DAB remains, especially in clots and spleen.

Methanol-hydrogen peroxide combines solvent and oxidizer. Methanol permeabilizes membranes, denatures some proteins, and helps peroxide reach intracellular heme. That is why it is classically chosen for frozen sections and for bloody specimens in which erythrocyte ghosts dominate the field. The tradeoff is epitope risk: methanol can reduce labeling of some surface antigens and can harden tissue before retrieval. Methanol-peroxide after a delicate HIER step can also lift sections as the slide dries.

A polymer system does not replace peroxide block. Polymer is biotin-free; it is not peroxidase-free. Tissue peroxidase still oxidizes DAB whether the secondary reagent is ABC-HRP or a micropolymer-HRP.

When to block relative to retrieval

Epitope retrieval and peroxide block both change the section. Order is part of the validated method, not a personal preference at the bench.

Block after retrieval is common on automated stainers. HIER opens the meshwork of fixed protein so peroxide reaches residual heme. Heat has already reduced much enzyme activity, but erythrocytes still show pseudoperoxidase. Applying 3% aqueous H2O2 after retrieval, rinsing, then applying primary antibody is the pattern many clinical polymer protocols use. Conceptually, the peroxidase block should sit after the last step that could restore or uncover enzyme and before HRP-conjugated detection reagent.

Block before retrieval remains common in manual recipes: dewax, rehydrate, apply methanol-H2O2, then retrieve. Methanol is easier to control on a rehydrated slide than on a loosely adhered retrieved section. If you place methanol-peroxide after high-temperature retrieval, sections detach. Aqueous peroxide before HIER is also used; heat then continues to denature enzyme.

Do not treat retrieval as a substitute block. HIER reduces AP and peroxidase but does not reliably silence red-cell pseudoperoxidase. Enzyme-induced epitope retrieval (EIER) with trypsin, pepsin, or proteinase K likewise does not replace H2O2.

Rinse as part of the block. Leftover peroxide is a dissolved inhibitor of the detection HRP you apply later. A beautiful quench of red cells followed by a weak true signal is often residual H2O2, not low antigen.

Levamisole for alkaline phosphatase

Levamisole (L-tetramisole) is a competitive inhibitor of most non-intestinal tissue AP isoforms. It is added to the chromogen-substrate working solution (commonly in the low millimolar range per kit insert), not as a separate slide pretreatment analogous to H2O2. It does nothing useful in an HRP-DAB run and must not be used as a substitute for peroxide.

Intestinal AP is relatively levamisole-resistant. Small-bowel mucosa can still show brush-border chromogen with AP-red detection even when levamisole is present. In that setting the fix is method choice (HRP instead of AP), not more levamisole.

FFPE plus HIER inactivates most endogenous AP, so many paraffin polymer-AP kits omit levamisole. Frozen sections, unfixed smears, and some cytology preparations require it if AP is the reporter. Historical strong-acid pretreatments also destroy AP but damage morphology and epitopes; levamisole in the substrate is the practical control.

Frozen versus FFPE

Frozen IHC is not the same protocol without the processor. Enzyme blocks are part of why frozen and FFPE validation are separate.

Over-blocking that weakens true signal

More peroxide is not more specificity.

• High concentration (jumping from 3% to 10–30%) or very long incubations oxidize amino acids in epitopes (methionine, cysteine, tryptophan) and can flatten true labeling.
• Failure to rinse leaves H2O2 in the buffer film; polymer-HRP or ABC-HRP is inactivated on contact.
• Sodium azide in some antibody diluents inhibits HRP; that is a reagent-inhibition trap related to the same enzyme, not a tissue block.
• Stacking methanol-peroxide, harsh HIER, and a concentrated polymer on a scant biopsy can yield pale specific stain and clean red cells—technically no background and diagnostically useless.

The RBC and granulocyte trap is the opposite error: under-blocking. Intact erythrocytes and neutrophils deposit DAB. Readers call it nonspecific cytoplasmic staining in a vascular tumor or positive blasts in a crushed marrow. Morphology (biconcave ghosts, granular myeloid cytoplasm) and a negative reagent control that is equally brown in the same cells give the diagnosis of endogenous peroxidase, not antigen.

In practice

A hemorrhagic glioblastoma stained with polymer-HRP/DAB shows brown red cells in the clot and clean tumor-cell nuclei for a nuclear marker. That is expected residual pseudoperoxidase, not failed antibody. If the same slide's nuclear marker is weak and red cells are stark brown after a 30-minute 10% aqueous block with a poor rinse, over-blocking plus residual peroxide is the better hypothesis. Return to a short 3% aqueous step after retrieval, rinse, and re-run before retitrating the primary.

For AP-red on a frozen small-bowel biopsy, levamisole will not erase brush-border AP. Choose HRP detection or interpret the brush border as endogenous enzyme. For a bone-marrow clot, plan on RBC pseudoperoxidase from the start: aqueous peroxide after retrieval, complete rinses, and morphology before you call cytoplasmic DAB in erythroid islands a blast marker.